4. Intangible Assets, Goodwill and Other (Tables)

9 Months Ended

Sep. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Changes to goodwill by segment

Changes to goodwill by segment were as follows (in millions):

	Life Science			Clinical Diagnostics			Total
Balances as of January 1, 2014:
Goodwill	$	209.0		$	337.0		$	546.0
Accumulated impairment losses	(27.2		)	(1.0		)	(28.2		)
Goodwill, net	181.8			336.0			517.8
Acquisitions	—			15.2			15.2
Currency fluctuations	(0.9		)	(18.6		)	(19.5		)
Balances as of September 30, 2014:
Goodwill	208.1			333.6			541.7
Accumulated impairment losses	(27.2		)	(1.0		)	(28.2		)
Goodwill, net	$	180.9		$	332.6		$	513.5

Schedule of identifiable purchased intangible assets with definite lives

Information regarding our identifiable purchased intangible assets with definite and indefinite lives is as follows (in millions):

	September 30, 2014
	Average Remaining Life (years)	Purchase Price		Accumulated Amortization			Net Carrying Amount
Customer relationships/lists	3-11	$	93.2	$	(43.1	)	$	50.1
Know how	1-11	188.3		(100.3		)	88.0
Developed product technology	5-13	106.5		(42.3		)	64.2
Licenses	1-12	44.2		(24.9		)	19.3
Tradenames	1-10	4.2		(2.5		)	1.7
Covenants not to compete	5-8	4.9		(1.1		)	3.8
Other	—	0.5		(0.5		)	—
Total definite-lived intangible assets		441.8		(214.7		)	$	227.1
In-process research and development		46.4		—			$	46.4
Total purchased intangible assets		$	488.2	$	(214.7	)	$	273.5

	December 31, 2013
	Average Remaining Life (years)	Purchase Price		Accumulated Amortization			Net Carrying Amount
Customer relationships/lists	1-11	$	99.8	$	(41.1	)	$	58.7
Know how	2-12	194.6		(89.3		)	105.3
Developed product technology	1-13	109.5		(36.2		)	73.3
Licenses	1-12	44.9		(22.4		)	22.5
Tradenames	1-9	4.3		(2.1		)	2.2
Covenants not to compete	5-9	4.9		(0.7		)	4.2
Other	—	0.6		(0.6		)	—
Total purchased intangible assets		$	458.6	$	(192.4	)	$	266.2